Because NF-κB signaling is critical for tumor initiation and progression [46], it is possible that pathoclinical conditions involving NF-κB may influence HE4 overexpression, either at the onset of oncogenic transformation or during progression to a more aggressive tumor phenotype. The gene discussed is WFDC2; the disease is neoplasm.